The drug discovery is defined as the process of identifying potential drugs and devising mechanisms for their use, which are put before medical practitioners by pharmaceutical companies in the form of phase I clinical trials. A drug discovery process begins with identifying or analyzing a compound or agent that has the potential to be a new drug.
Highlighted with 86 tables and 97 figures, this 181-page report “Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global drug discovery market and all its sub-segments through extensively detailed classifications.
Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents. Growing demand for innovative products, rising prevalence of cancer type diseases and increasing health concerns across the globe are the major factors expected to drive the global drug discovery market.
Global Drug Discovery Market Analysis is a report that focuses on the market size, share and trends of the Global Drug Discovery market. The study covers all the top manufacturers in global market and shares detailed information about their competitive strategy, product portfolio, revenue and gross margin. The data obtained from this report acts as an important factor to research various aspects of Global Drug Discovery market globally.
Request Research Sample with Latest Industry Insights (181+ Pages Report): https://altusmarketresearch.com/reports/sample/29838
The global market for drug discovery is fast-growing, with the ability to discover new drugs. Drug discovery can be categorized using target-directed therapies, medicinal chemists are working on different drug models to study and understand the mechanism of diseases. Drug discovery can be further segmented on the basis of target and approved drugs.
Growing expenditure on healthcare and aging population are driving the research and development (R&D) activities of the pharmaceutical industries worldwide.
Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Small Molecule Drugs
• Biologic Drugs
Based on Service, the global Drug Discovery Market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Medicinal Chemical Services
• Biological Services
• Drug Metabolism and Pharmacokinetics (DMPK) Services
• Other Pharmaceutical Services
Based on Process, the global Drug Discovery Market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation
Based on Technology, the global Drug Discovery Market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• High Throughput Screening
• Combinatorial Chemistry
• Pharmacogenomics and Pharmacogenetics
• Nanotechnology
• Bioanalytical Instruments
• Biochips
• Bioinformatics
• Other Technologies
Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Oncology
• Neurology
• Infectious and Immune System Diseases
• Digestive System Diseases
• Cardiovascular Diseases
• Diabetes
• Respiratory Disease
• Other Therapeutic Areas
Based on End User, the global Drug Discovery Market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Research Institutes
• Other End Users
Key Players:
Abbott Laboratories Inc.
Agilent Technologies Inc.
Astrazeneca plc
Bayer AG
Charles River Laboratories International Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Shimadzu Corp
Thermo Fisher Scientific Inc.
